🦊/Companies

Haima

2 known investors

Find your way into Haima

87 people in our graph share verified history with the Haima team — schools, employers, funds. One of them is your warm intro.

Akhil Saklechaunlockedknows Michael Bruckman · together at Case Western Reserve University (overlapped)
×3knows the team · via University of South Carolina
×4knows the team · via University at Buffalo
×3knows the team · via Naval Research Laboratory
knows the team · via Case Western Reserve University

Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders. Its lead technology, SynthoPlate, is a fully-synthetic hemostatic agent that acts at the injury site to amplify the body's natural clotting mechanisms.

Founders & leadership

ASAnirban Sen Gupta
Anirban Sen GuptaCTO
MBMichael Bruckman
Michael BruckmaninCEOMichael Bruckman holds a Ph.D. in organic chemistry and has training in biomedical engineering and management. He is CEO of Haima Therapeutics, which develops synthetic hemostatic agents for bleeding and blood disorders.
MNMatthew Neal
Matthew NealCMO
CPChrista Pawlowski
Christa PawlowskiCOO and EVP of R&D
TPTimothy Pelura
Timothy PeluraExecutive Chair

Investors · 2

Competitors · 1

by search overlap

Companies competing with Haima for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Haima do?
Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders. Its lead technology, SynthoPlate, is a fully-synthetic hemostatic agent that acts at the injury site to amplify the body's natural clotting mechanisms.
Who founded Haima?
Haima was founded by Anirban Sen Gupta.
Who are Haima's investors?
Haima's investors include CWRU Technology Ventures, Tachyon Ventures.